Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Medical Devices ETF

51.10
+0.15000.29%
Post-market: 51.100.00000.00%19:30 EDT
Volume:1.74M
Turnover:88.30M
Market Cap:3.45B
PE:12.80
High:51.13
Open:50.87
Low:50.46
Close:50.95
52wk High:64.71
52wk Low:47.37
Shares:67.45M
Float Shares:67.45M
Volume Ratio:0.61
T/O Rate:2.58%
Dividend:0.26
Dividend Rate:0.51%
EPS(TTM):3.99
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Debate Heats Up

Simply Wall St.
·
Oct 03

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

BD Declares R$ 0.7396650250 Dividend Per Unit for 3Q 2026

Reuters
·
Oct 03

BDX’s PureWick ICU Trial: A Quiet Catalyst for Hospital Device Growth

TIPRANKS
·
Oct 03

Argus Research Adjusts Becton, Dickinson and Company Price Target to $210 From $180, Maintains Buy Rating

MT Newswires Live
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)

TIPRANKS
·
Oct 02

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Oct 02

Edwards Lifesciences Receives FDA Approval for Autus Valve, the First Surgical Pulmonary Valve for Pediatric Patients

THOMSON REUTERS
·
Oct 02

US FDA - Approves Autus Size-Adjustable Valve for Pediatric Congenital Pulmonary Valve Disease

THOMSON REUTERS
·
Oct 02

US FDA - Edwards Lifesciences Receives FDA Approval for Autus Size-Adjustable Valve

THOMSON REUTERS
·
Oct 02

Stryker to Webcast Third-Quarter 2026 Results Update

Reuters
·
Oct 01

Press Release: Stryker to Announce Third Quarter 2026 Financial Results

Dow Jones
·
Oct 01

Agilent Technologies Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 01

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Edwards Lifesciences' TAVR Evaluation in Moderate Aortic Stenosis Among Most Awaited Clinical Trial Readouts, Oppenheimer Says

MT Newswires Live
·
Sep 30

Abbott Launches SimpleScreen Blood Test for Colorectal Cancer

MT Newswires Live
·
Sep 30

Abbott to Release Q3 2026 Results, Host Earnings Call

Reuters
·
Sep 30

Abbott announces U.S. commercial launch of SimpleScreen CRC

TIPRANKS
·
Sep 30

Abbott Launches Simplescreen™ Crc Blood Test, Joining Cologuard Plus® in Its Colorectal Cancer Screening Portfolio

THOMSON REUTERS
·
Sep 30